TP53 and neoplasm: In vitro and in vivo analyses, including patient-derived cells, tumor organoids, and xenograft models, revealed strong synergy between SINE and ALK-TKIs, characterized by G1 cell-cycle arrest, p53 accumulation, and apoptosis.